E
Emanuela Merla
Researcher at Casa Sollievo della Sofferenza
Publications - 22
Citations - 1353
Emanuela Merla is an academic researcher from Casa Sollievo della Sofferenza. The author has contributed to research in topics: Transplantation & Lymphoma. The author has an hindex of 13, co-authored 21 publications receiving 1263 citations. Previous affiliations of Emanuela Merla include University of Bologna.
Papers
More filters
Journal ArticleDOI
Oral melphalan and prednisone chemotherapy plus thalidomide compared with melphalan and prednisone alone in elderly patients with multiple myeloma: randomised controlled trial
Antonio Palumbo,Sara Bringhen,Tommaso Caravita,Emanuela Merla,Vincenzo Capparella,Vincenzo Callea,Clotilde Cangialosi,Mariella Grasso,Fausto Rossini,Monica Galli,Lucio Catalano,Elena Zamagni,Maria Teresa Petrucci,Valerio De Stefano,Manuela Ceccarelli,Maria Teresa Ambrosini,Ilaria Avonto,Patrizia Falco,Giovannino Ciccone,Anna Marina Liberati,Pellegrino Musto,Mario Boccadoro +21 more
TL;DR: Oral MPT is an effective first-line treatment for elderly patients with multiple myeloma and anticoagulant prophylaxis reduces frequency of thrombosis.
Journal ArticleDOI
Primary intestinal lymphoma: clinical and therapeutic features of 32 patients.
Pier Luigi Zinzani,Massimo Magagnoli,G Pagliani,Maurizio Bendandi,Franco Gherlinzoni,Emanuela Merla,Marzia Salvucci,Tura S +7 more
TL;DR: The experience confirms the efficacy of the surgery-chemotherapy combination in obtaining a good remission rate for localized early primary intestinal lymphoma and indicates that this combination represents the only means for managing complications.
Journal ArticleDOI
Adult Lymphoblastic Lymphoma: Clinical Features and Prognostic Factors in 53 Patients
Pier Luigi Zinzani,Maurizio Bendandi,Giuseppe Visani,Filippo Gherlinzoni,Giovanni Frezza,Emanuela Merla,S. Manfroi,Alessandro Gozzetti,Sante Tura +8 more
TL;DR: The role of intensive polychemotherapeutic regimens including CNS prophylaxis, the significance of a score model of prognostic factors, and of the role of ABMT (or allogeneic bone marrow transplantation) in the treatment of adult LBL are confirmed.
Journal ArticleDOI
Nongastrointestinal mucosa-associated lymphoid tissue (MALT) lymphomas: Clinical and therapeutic features of 24 localized patients
Pier Luigi Zinzani,Massimo Magagnoli,Stefano Ascani,Paolo Ricci,Venerino Poletti,Franco Gherlinzoni,G. Frezza,Maurizio Bendandi,C. Stefanetti,Emanuela Merla,S. A. Pileri,Tura S +11 more
TL;DR: These data confirm the significant efficacy of different therapeutic approaches to specific sites in obtaining a good remission rate for nongastrointestinal localized low-grade MALT lymphomas.
Journal ArticleDOI
Fludarabine-mitoxantrone combination-containing regimen in recurrent low-grade non-Hodgkin's lymphoma.
Pier Luigi Zinzani,Maurizio Bendandi,Massimo Magagnoli,Franco Gherlinzoni,Emanuela Merla,Tura S +5 more
TL;DR: These data confirm the significant efficacy of the FMP fludarabine-mitoxantrone combination regimen in obtaining a good remission rate with moderate toxicity in a particular subset of recurrent LG-NHL.